BIEL vs ABT: Which Stock is Better?

Side-by-side comparison of Bioelectronics Corp and Abbott Laboratories in 2026

Comparison Updated:

BIEL

Bioelectronics Corp

ABT

Abbott Laboratories

$95.84

Key Metrics Comparison

MetricBIELABTWinner
Market Cap$8.65M$154.15BABT
P/E RatioN/A24.79ABT
EPS (TTM)$N/A$N/ATie
Revenue Growth0.0%0.0%Tie
Gross Margin0.0%0.0%Tie

Analyze BIEL

Full quant analysis

Analyze ABT

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is BIEL or ABT a better investment?

Comparing BIEL and ABT: Bioelectronics Corp has a market cap of $8.65M while Abbott Laboratories has $154.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between BIEL and ABT?

BIEL (Bioelectronics Corp) and ABT (Abbott Laboratories) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: BIEL or ABT?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: BIEL or ABT?

Both BIEL and ABT show similar growth rates. Check our detailed analysis for quarterly trends.

Which company is more profitable: BIEL or ABT?

Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.

Which is the larger company: BIEL or ABT?

Abbott Laboratories (ABT) is larger with a market cap of $154.15B compared to $8.65M for BIEL.

Should I buy BIEL or ABT in 2026?

Both BIEL and ABT have investment merit. BIEL trades at $N/A while ABT trades at $95.84. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between BIEL and ABT stock?

Key differences: Market Cap ($8.65M vs $154.15B), P/E Ratio (N/A vs 24.8x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).

Should I buy BIEL or ABT in 2026?

The choice between BIEL and ABT depends on your investment goals. ABT shows higher revenue growth (0.0%). ABT has better margins (0.0%). Consider your risk tolerance and time horizon.

What is the market cap comparison between BIEL and ABT?

BIEL (Bioelectronics Corp) has a market cap of $8.65M, while ABT (Abbott Laboratories) has a market cap of $154.15B. ABT is the larger company by market value.

Popular Stock Comparisons